Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Steiner, M; Attarbaschi, A; Dworzak, M; Strobl, H; Pickl, W; Kornmüller, R; Haas, O; Gadner, H; Mann, G; Austrian Berlin-Frankfurt-Münster Study Group.
Cytochemically myeloperoxidase positive childhood acute leukemia with lymphoblastic morphology treated as lymphoblastic leukemia.
J Pediatr Hematol Oncol. 2010; 32(1):e4-e7 Doi: 10.1097/MPH.0b013e3181b1ee65
PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Strobl Herbert
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
SUMMARY: Cytochemical myeloperoxidase (MPO) positivity represents the gold standard for discrimination between lymphatic and myeloid blasts. Rarely, cytochemical MPO reaction may be positive in >or=3% of blasts with clear lymphoblastic morphology. We present 5 patients with cytochemically MPO-positive acute leukemia classified as lymphoblastic by cytomorphology and lymphoblastic (n=3) or biphenotypic (n=2) by immunophenotyping, who entered first-line treatment for lymphoblastic leukemia. The former 3 are in first remission and both with biphenotypic leukemia relapsed with acute myeloid leukemia. The study primarily shows that cytochemical MPO expression in childhood acute leukemia revealing typical lymphoblastic morphology and phenotype does rarely exist. Although a small number of patients studied, cytochemical MPO expression in acute leukemia does not seem to require myeloid leukemia treatment in case of otherwise lymphoblastic cytomorphology and phenotype.
Find related publications in this database (using NLM MeSH Indexing)
Humans -
Immunophenotyping -
Leukemia, Myeloid, Acute - classification Leukemia, Myeloid, Acute - etiology
Neoplasms, Second Primary -
Peroxidase - analysis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Recurrence -
Remission Induction -
Treatment Outcome -

© Med Uni Graz Impressum